{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:15:12Z","timestamp":1782184512453,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jiac.2021.07.003","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T04:57:09Z","timestamp":1626757029000},"page":"1591-1595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic values of HNP 1-3 and procalcitonin levels in synovial fluid aspirates in the differential diagnosis between septic arthritis and noninfectious arthritis"],"prefix":"10.1016","volume":"27","author":[{"given":"Do\u011fan","family":"Akdo\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5408-0905","authenticated-orcid":false,"given":"Mustafa","family":"G\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra Akkan","family":"Kuzucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"\u00c7al\u0131\u015fkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakup","family":"Kuzucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Akp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jiac.2021.07.003_bib1","first-page":"260","article-title":"Septic arthritis: a 12 years retrospective study in a rheumatological university clinic","volume":"60","author":"Favero","year":"2008","journal-title":"Reumatismo"},{"issue":"6","key":"10.1016\/j.jiac.2021.07.003_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-013-0332-4","article-title":"Clinical management of septic arthritis","volume":"15","author":"Sharff","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.jiac.2021.07.003_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/rheumatology\/40.1.24","article-title":"A prospective 2-year study of 75 patients with adult-onset septic arthritis","volume":"40","author":"Gupta","year":"2001","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.jiac.2021.07.003_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.berh.2015.05.008","article-title":"Septic arthritis in immunocompetent and immunosuppressed hosts","volume":"29","author":"Wang","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"991","key":"10.1016\/j.jiac.2021.07.003_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/ard.2006.058909","article-title":"Management of septic arthritis: asystematic review","volume":"84","author":"Mathews","year":"2008","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.jiac.2021.07.003_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00296-012-2363-y","article-title":"Septic versus inflammatory arthritis: discriminating the ability of serum inflammatory markers","volume":"33","author":"Talebi-Taher","year":"2013","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.jiac.2021.07.003_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1302\/2046-3758.71.BJR-2017-0323","article-title":"Serum biomarkers in periprosthetic joint infections","volume":"7","author":"Saleh","year":"2018","journal-title":"Bone Joint Res"},{"issue":"8","key":"10.1016\/j.jiac.2021.07.003_bib8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.ajem.2017.06.014","article-title":"Serum procalcitonin levels as a diagnostic marker for septic arthritis: a meta-analysis","volume":"35","author":"Zhao","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"12","key":"10.1016\/j.jiac.2021.07.003_bib9","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s00264-016-3306-0","article-title":"Alpha-defensin novel synovial fluid biomarker for the diagnosis of periprosthetic joint infection","volume":"40","author":"Pupaibool","year":"2016","journal-title":"Int Orthop"},{"key":"10.1016\/j.jiac.2021.07.003_bib10","series-title":"Septic arthritis iCn adults. US: UpToDate","first-page":"1","author":"Goldenberg","year":"2012"},{"issue":"2","key":"10.1016\/j.jiac.2021.07.003_bib11","first-page":"1068","article-title":"Septic arthritis of the hip diagnosis and management","volume":"4","author":"Nusem","year":"2016","journal-title":"Ann Orthop Rheumatol"},{"issue":"4","key":"10.1016\/j.jiac.2021.07.003_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/RHU.0000000000000249","article-title":"Acute bacterial arthritis: how long should you wait for culture results?","volume":"21","author":"Balderia","year":"2015","journal-title":"J Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.jiac.2021.07.003_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mpmed.2014.02.007","article-title":"Bone and joint infections","volume":"42","author":"Mathews","year":"2014","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jiac.2021.07.003_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00124743-200204000-00001","article-title":"Another look at synovial fluid leukocytosis and infection","volume":"8","author":"Coutlakis","year":"2002","journal-title":"JCR J Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.jiac.2021.07.003_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1573397113666170329123308","article-title":"The limitations of Gram-stain microscopy of synovial fluid in concomitant septic and crystal arthritis","volume":"14","author":"Stirling","year":"2018","journal-title":"Curr Rheumatol Rev"},{"issue":"9","key":"10.1016\/j.jiac.2021.07.003_bib16","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/imj.13969","article-title":"Acute arthritis: predictive factors and currentpractice in the approach to diagnosis and management across two hospitals inSydney","volume":"48","author":"Pavic","year":"2018","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.jiac.2021.07.003_bib17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.arth.2016.10.001","article-title":"M. YanProcalcitonin and \u03b1-defensin for diagnosis of periprosthetic joint infections","volume":"32","author":"Xie","year":"2017","journal-title":"J Arthroplasty"},{"issue":"4","key":"10.1016\/j.jiac.2021.07.003_bib18","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s15010-013-0467-2","article-title":"Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening","volume":"41","author":"Saeed","year":"2013","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.jiac.2021.07.003_bib19","article-title":"Diagnostic value of serum and synovial procalcitonin in acute arthritis: a prospective study of 42 patients","volume":"23","author":"Martinot","year":"2005","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.jiac.2021.07.003_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jbspin.2007.07.012","article-title":"Procalcitonin, C reactive protein, and complement 3a assays in synovial fluid for diagnosing septic arthritis: preliminary results","volume":"75","author":"Streit","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.jiac.2021.07.003_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3892\/etm.2014.1870","article-title":"Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis","volume":"8","author":"Wang","year":"2014","journal-title":"Exper Therapeut Med"},{"issue":"1","key":"10.1016\/j.jiac.2021.07.003_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/AAC.49.1.269-275.2005","article-title":"Antibacterial activity and specificity of the six human alpha- defensins","volume":"49","author":"Ericksen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.jiac.2021.07.003_bib23","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1007\/s00264-016-3306-0","article-title":"Alpha-defensin novel synovial fluid biomarker for the diagnosis of periprosthetic joint infection","volume":"40","author":"Pupaibool","year":"2016","journal-title":"Int Orthop"},{"issue":"17","key":"10.1016\/j.jiac.2021.07.003_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2106\/JBJS.M.01316","article-title":"Combined measurement of synovial fluid \u03b1-Defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection","volume":"96","author":"Deirmengian","year":"2014","journal-title":"JBJS"},{"issue":"12","key":"10.1016\/j.jiac.2021.07.003_bib25","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1007\/s11999-014-3900-7","article-title":"The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty","volume":"472","author":"Bingham","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"10.1016\/j.jiac.2021.07.003_bib26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.arth.2015.09.035","article-title":"Alpha-defensin accuracy to diagnose periprosthetic joint infection-best available test?","volume":"31","author":"Frangiamore","year":"2016","journal-title":"J Arthroplasty"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:08Z","timestamp":1761159788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21001860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1341321X21001860"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.07.003","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic values of HNP 1-3 and procalcitonin levels in synovial fluid aspirates in the differential diagnosis between septic arthritis and noninfectious arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}